- 現金殖利率: N/A、總殖利率: 0、5年平均現金配發率: N/A
- 要留意資產負債表的未分配盈餘和配息能力, 如果為負值, 可能會無法發放股利
- 股利有2個稅要支出, 分別是綜合所得稅和健保補充保費(單筆股利達2萬元以上, 課2.11%)
EPS YoY | 現金股利 YoY | 股票股利 YoY | 現金配發率 YoY | 股票配發率 YoY | 全部配發率 YoY | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | -3.05 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2022 (9) | -0.98 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2021 (8) | -2.18 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2020 (7) | -1.16 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2019 (6) | -2.23 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2018 (5) | -2.06 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2017 (4) | -1.96 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
2016 (3) | 0.68 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 0 |
EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | |||||||
---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | -0.91 | 13.33 | 12.5 | -0.64 | 30.43 | 33.33 | -3.24 | -39.06 | -42.73 |
24Q2 (19) | -1.05 | -17.98 | -9.38 | -0.92 | 4.17 | -4.55 | -2.33 | -161.8 | -87.9 |
24Q1 (18) | -0.89 | -15.58 | -217.86 | -0.96 | 36.84 | -380.0 | -0.89 | 70.82 | -217.86 |
23Q4 (17) | -0.77 | 25.96 | -71.11 | -1.52 | -58.33 | -58.33 | -3.05 | -34.36 | -211.22 |
23Q3 (16) | -1.04 | -8.33 | -131.11 | -0.96 | -9.09 | -166.67 | -2.27 | -83.06 | -328.3 |
23Q2 (15) | -0.96 | -242.86 | -3300.0 | -0.88 | -340.0 | -414.29 | -1.24 | -342.86 | -1450.0 |
23Q1 (14) | -0.28 | 37.78 | -154.55 | -0.20 | 79.17 | -66.67 | -0.28 | 71.43 | -154.55 |
22Q4 (13) | -0.45 | 0.0 | -36.36 | -0.96 | -166.67 | 25.0 | -0.98 | -84.91 | 55.05 |
22Q3 (12) | -0.45 | -1600.0 | 26.23 | -0.36 | -228.57 | 30.77 | -0.53 | -562.5 | 72.54 |
22Q2 (11) | 0.03 | 127.27 | 105.66 | 0.28 | 333.33 | 146.67 | -0.08 | 27.27 | 93.98 |
22Q1 (10) | -0.11 | 66.67 | 86.42 | -0.12 | 90.63 | 86.96 | -0.11 | 94.95 | 86.42 |
21Q4 (9) | -0.33 | 45.9 | 70.27 | -1.28 | -146.15 | -6.67 | -2.18 | -12.95 | -87.93 |
21Q3 (8) | -0.61 | -15.09 | 32.97 | -0.52 | 13.33 | 45.83 | -1.93 | -45.11 | -3760.0 |
21Q2 (7) | -0.53 | 34.57 | -103.85 | -0.60 | 34.78 | -275.0 | -1.33 | -64.2 | -254.65 |
21Q1 (6) | -0.81 | 27.03 | -172.32 | -0.92 | 23.33 | -192.0 | -0.81 | 30.17 | -172.32 |
20Q4 (5) | -1.11 | -21.98 | -35.37 | -1.20 | -25.0 | -76.47 | -1.16 | -2220.0 | 47.98 |
20Q3 (4) | -0.91 | -250.0 | 0.0 | -0.96 | -500.0 | 0.0 | -0.05 | -105.81 | 0.0 |
20Q2 (3) | -0.26 | -123.21 | 0.0 | -0.16 | -116.0 | 0.0 | 0.86 | -23.21 | 0.0 |
20Q1 (2) | 1.12 | 236.59 | 0.0 | 1.00 | 247.06 | 0.0 | 1.12 | 150.22 | 0.0 |
19Q4 (1) | -0.82 | 0.0 | 0.0 | -0.68 | 0.0 | 0.0 | -2.23 | 0.0 | 0.0 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/11 | 0.03 | -12.46 | -68.06 | 0.39 | -85.31 | 0.1 | N/A | 泰國生產訂單減少,營收下降 | ||
2024/10 | 0.04 | 39.32 | -56.02 | 0.36 | -86.03 | 0.1 | N/A | 泰國生產訂單減少,營收下降 | ||
2024/9 | 0.03 | -22.0 | -82.0 | 0.32 | -87.1 | 0.1 | 2.7 | 泰國生產訂單減少,營收下降 | ||
2024/8 | 0.04 | -2.27 | -79.63 | 0.29 | -87.45 | 0.11 | 2.35 | 泰國生產訂單減少,營收下降 | ||
2024/7 | 0.04 | -14.09 | -83.14 | 0.25 | -88.09 | 0.09 | 2.85 | 泰國生產訂單減少,營收下降 | ||
2024/6 | 0.04 | 169.77 | -86.94 | 0.22 | -88.65 | 0.15 | 1.83 | 泰國生產訂單減少,營收下降 | ||
2024/5 | 0.02 | -82.41 | -93.55 | 0.17 | -89.0 | 0.13 | 2.07 | 泰國生產訂單減少,致本月營收下降 | ||
2024/4 | 0.09 | 254.61 | -61.76 | 0.16 | -88.17 | 0.14 | 1.98 | 客戶訂單減少,致本月營收下降 | ||
2024/3 | 0.03 | 18.21 | -90.33 | 0.07 | -93.75 | 0.07 | 5.78 | 客戶訂單減少,致本月營收下降 | ||
2024/2 | 0.02 | -5.65 | -95.06 | 0.04 | -94.8 | 0.18 | 2.17 | 客戶訂單減少,致本月營收下降 | ||
2024/1 | 0.02 | -83.86 | -94.53 | 0.02 | -94.53 | 0.27 | 1.49 | 客戶訂單減少,致本月營收下降 | ||
2023/12 | 0.14 | 32.07 | -68.01 | 2.79 | -36.49 | 0.33 | 1.31 | 客戶訂單減少,致本月營收下降 | ||
2023/11 | 0.11 | 20.52 | -69.42 | 2.65 | -33.0 | 0.35 | 1.26 | 客戶訂單減少,致本月營收下降 | ||
2023/10 | 0.09 | -42.99 | -71.33 | 2.55 | -29.49 | 0.42 | 1.05 | 客戶訂單減少,致本月營收下降 | ||
2023/9 | 0.15 | -11.73 | -55.76 | 2.46 | -25.6 | 0.55 | 1.37 | 客戶訂單減少,致本月營收下降 | ||
2023/8 | 0.18 | -19.09 | -45.0 | 2.3 | -22.03 | 0.72 | 1.05 | - | ||
2023/7 | 0.22 | -33.47 | -32.18 | 2.13 | -19.26 | 0.79 | 0.95 | - | ||
2023/6 | 0.33 | 33.18 | -26.35 | 1.91 | -17.48 | 0.8 | 1.32 | - | ||
2023/5 | 0.24 | 4.34 | -43.93 | 1.59 | -15.39 | 0.74 | 1.43 | - | ||
2023/4 | 0.23 | -10.34 | -48.67 | 1.34 | -6.76 | 0.93 | 1.14 | - | ||
2023/3 | 0.26 | -39.67 | -24.38 | 1.11 | 12.67 | 1.11 | 1.27 | - | ||
2023/2 | 0.43 | 4.49 | 13.62 | 0.85 | 32.72 | 1.29 | 1.1 | - | ||
2023/1 | 0.41 | -5.54 | 60.99 | 0.41 | 60.99 | 1.2 | 1.17 | 客戶訂單增加且泰國工廠產能提升 | ||
2022/12 | 0.44 | 26.26 | 220.34 | 4.4 | 11.54 | 1.09 | 1.32 | 客戶訂單增加且泰國工廠產能提升 | ||
2022/11 | 0.35 | 12.97 | 39.24 | 3.96 | 4.03 | 1.0 | 1.43 | - | ||
2022/10 | 0.31 | -12.02 | 28.74 | 3.61 | 1.56 | 0.98 | 1.48 | - | ||
2022/9 | 0.35 | 9.76 | -7.29 | 3.31 | -0.39 | 0.99 | 1.07 | - | ||
2022/8 | 0.32 | -0.24 | -29.89 | 2.96 | 0.48 | 1.08 | 0.98 | - | ||
2022/7 | 0.32 | -27.74 | -23.28 | 2.64 | 6.03 | 1.2 | 0.89 | - | ||
2022/6 | 0.44 | 1.39 | 19.71 | 2.32 | 11.93 | 1.33 | 0.67 | - | ||
2022/5 | 0.44 | -4.47 | 35.09 | 1.88 | 10.24 | 1.24 | 0.73 | - | ||
2022/4 | 0.46 | 32.06 | 66.08 | 1.44 | 4.43 | 1.18 | 0.76 | 係泰國廠已設置完成,並正式量產。 | ||
2022/3 | 0.35 | -9.34 | 3.97 | 0.98 | -10.9 | 0.98 | 0.63 | - | ||
2022/2 | 0.38 | 48.04 | 41.8 | 0.64 | -17.3 | 0.78 | 0.8 | - | ||
2022/1 | 0.26 | 87.95 | -48.86 | 0.26 | -48.86 | 0.64 | 0.96 | - | ||
2021/12 | 0.14 | -45.11 | -73.63 | 3.94 | -30.75 | 0.63 | 1.04 | 12月因屆歐洲客戶及泰國工廠國定年假期間, 故精品部之出貨量較少所致。 | ||
2021/11 | 0.25 | 4.45 | -48.59 | 3.81 | -26.44 | 0.87 | 0.75 | - | ||
2021/10 | 0.24 | -36.65 | -51.89 | 3.56 | -24.15 | 1.07 | 0.61 | 受疫情影響,星馬保健產品及餐飲業務萎縮 | ||
2021/9 | 0.38 | -16.99 | -21.4 | 3.32 | -20.87 | 1.25 | 0.6 | - | ||
2021/8 | 0.45 | 9.15 | -7.61 | 2.94 | -20.8 | 1.24 | 0.6 | - | ||
2021/7 | 0.42 | 12.75 | 24.67 | 2.49 | -22.81 | 1.11 | 0.68 | - | ||
2021/6 | 0.37 | 14.42 | -29.79 | 2.07 | -28.3 | 0.97 | 0.47 | - | ||
2021/5 | 0.32 | 17.44 | -10.23 | 1.7 | -27.96 | 0.93 | 0.48 | - | ||
2021/4 | 0.27 | -17.32 | -26.64 | 1.38 | -31.15 | 0.88 | 0.51 | - | ||
2021/3 | 0.33 | 23.63 | -39.56 | 1.1 | -32.18 | 1.1 | 0.43 | - | ||
2021/2 | 0.27 | -46.6 | -25.26 | 0.77 | -28.42 | 1.29 | 0.37 | - | ||
2021/1 | 0.5 | -3.11 | -30.0 | 0.5 | -30.0 | 1.51 | 0.32 | - | ||
2020/12 | 0.52 | 7.03 | -31.76 | 5.7 | -20.33 | 1.5 | 0.13 | - | ||
2020/11 | 0.49 | -2.26 | -39.1 | 5.18 | -18.93 | 1.46 | 0.14 | - | ||
2020/10 | 0.5 | 3.49 | -20.09 | 4.69 | -15.1 | 1.47 | 0.14 | - | ||
2020/9 | 0.48 | -2.42 | 13.96 | 4.19 | -15.52 | 1.31 | 0.2 | - | ||
2020/8 | 0.49 | 47.29 | -0.37 | 3.71 | -18.28 | 1.35 | 0.19 | - | ||
2020/7 | 0.33 | -36.5 | -52.0 | 3.22 | -20.44 | 1.22 | 0.21 | 因新冠肺炎疫情影響且客戶流失 | ||
2020/6 | 0.53 | 46.3 | 38.17 | 2.89 | -12.37 | 1.26 | 0.31 | - | ||
2020/5 | 0.36 | -4.03 | -21.0 | 2.36 | -19.0 | 1.28 | 0.3 | - | ||
2020/4 | 0.37 | -31.88 | -49.45 | 2.0 | -18.68 | 1.28 | 0.3 | - | ||
2020/3 | 0.55 | 52.89 | -4.23 | 1.63 | -4.56 | 1.63 | 0.31 | - | ||
2020/2 | 0.36 | -49.99 | -39.22 | 1.08 | -3.53 | 1.84 | 0.28 | - | ||
2020/1 | 0.72 | -5.53 | 36.85 | 0.72 | 36.85 | 0.0 | N/A | - | ||
2019/12 | 0.76 | -4.48 | 40.32 | 7.15 | 39.34 | 0.0 | N/A | - |